Lv11
20 积分 2025-03-22 加入
Synthetic Approaches to the New Drugs Approved During 2020
7天前
已完结
Faculty Opinions recommendation of Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)
14天前
已完结
Testing the continuum of delusional beliefs: An experimental study using virtual reality
22天前
已完结
Prediction of Drug–Drug Interactions with Ensartinib as a Time-Dependent CYP3A Inhibitor Using Physiologically Based Pharmacokinetic Model
1个月前
已完结
Synthetic Approaches to the New Drugs Approved During 2020
1个月前
已完结
皖公网安备34019202002308
